Spots Global Cancer Trial Database for Durvalumab Long-Term Safety and Efficacy Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Durvalumab Long-Term Safety and Efficacy Study
Official Title: An Open-Label, Multi-Center, Global Study to Evaluate Long Term Safety and Efficacy in Patients Who Are Receiving or Who Previously Received Durvalumab in Other Protocols (WAVE)
Study ID: NCT04078152
Conditions
Interventions
Study Description
Brief Summary: The aims of the study are to monitor the long-term safety of durvalumab, to provide continued treatment or retreatment with durvalumab to eligible patients, and to collect overall survival (OS) information.
Detailed Description: This is a multicenter, open-label, global study that will enroll patients who are currently receiving durvalumab monotherapy, or have previously received durvalumab as monotherapy or in combination with any other approved or investigational anticancer agents, in an eligible AstraZeneca/MedImmune-sponsored clinical study.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Fullerton, California, United States
Research Site, Washington, District of Columbia, United States
Research Site, Augusta, Georgia, United States
Research Site, Baltimore, Maryland, United States
Research Site, Minneapolis, Minnesota, United States
Research Site, Saint Louis, Missouri, United States
Research Site, Mineola, New York, United States
Research Site, Chapel Hill, North Carolina, United States
Research Site, Huntersville, North Carolina, United States
Research Site, Greenville, South Carolina, United States
Research Site, Nashville, Tennessee, United States
Research Site, Dallas, Texas, United States
Research Site, Rosario, , Argentina
Research Site, Box Hill, , Australia
Research Site, Melbourne, , Australia
Research Site, Brussels, , Belgium
Research Site, Kortrijk, , Belgium
Research Site, Leuven, , Belgium
Research Site, Florianópolis, , Brazil
Research Site, Ijuí, , Brazil
Research Site, Porto Alegre, , Brazil
Research Site, Sao Jose Do Rio Preto, , Brazil
Research Site, Sofia, , Bulgaria
Research Site, Calgary, Alberta, Canada
Research Site, Toronto, CA, Canada
Research Site, Newmarket, Ontario, Canada
Research Site, Sudbury, Ontario, Canada
Research Site, Santiago, , Chile
Research Site, Olomouc, , Czechia
Research Site, Brest Cedex, , France
Research Site, Lille, , France
Research Site, Lyon Cedex 08, , France
Research Site, Dresden, , Germany
Research Site, Hannover, , Germany
Research Site, Holargos, Athens, , Greece
Research Site, Budapest, , Hungary
Research Site, Miskolc, , Hungary
Research Site, Chennai, , India
Research Site, Haifa, , Israel
Research Site, Bunkyo-ku, , Japan
Research Site, Fukushima-shi, , Japan
Research Site, Isehara-shi, , Japan
Research Site, Izumi-shi, , Japan
Research Site, Kishiwada-shi, , Japan
Research Site, Koto-ku, , Japan
Research Site, Nagaoka-shi, , Japan
Research Site, Nagoya-shi, , Japan
Research Site, Natori-shi, , Japan
Research Site, Okayama-shi, , Japan
Research Site, Osaka-shi, , Japan
Research Site, Saga-shi, , Japan
Research Site, Suita-shi, , Japan
Research Site, Sunto-gun, , Japan
Research Site, Tokushima-shi, , Japan
Research Site, Yokohama-shi, , Japan
Research Site, Daegu, , Korea, Republic of
Research Site, Gwangju, , Korea, Republic of
Research Site, Gyeongsangnam-do, , Korea, Republic of
Research Site, Seo-Gu, , Korea, Republic of
Research Site, Seongnam-si, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Kuching, , Malaysia
Research Site, Amsterdam, , Netherlands
Research Site, Arnhem, , Netherlands
Research Site, Olsztyn, , Poland
Research Site, Łódź, , Poland
Research Site, Łódź, , Poland
Research Site, Craiova, , Romania
Research Site, Suceava, , Romania
Research Site, Arkhangelsk, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Omsk, , Russian Federation
Research Site, pos.Pesochnyi, , Russian Federation
Research Site, Saint-Petersburg, , Russian Federation
Research Site, Saint-Petersburg, , Russian Federation
Research Site, Sremska Kamenica, , Serbia
Research Site, Badalona, , Spain
Research Site, Barcelona, , Spain
Research Site, Barcelona, , Spain
Research Site, Barcelona, , Spain
Research Site, Girona, , Spain
Research Site, Jaén, , Spain
Research Site, Madrid, , Spain
Research Site, Madrid, , Spain
Research Site, Marbella, , Spain
Research Site, Málaga, , Spain
Research Site, Valencia, , Spain
Research Site, Bellinzona, , Switzerland
Research Site, Lausanne, , Switzerland
Research Site, New Taipei, , Taiwan
Research Site, Taichung, , Taiwan
Research Site, Taichung, , Taiwan
Research Site, Tainan, , Taiwan
Research Site, Taipei, , Taiwan
Research Site, Bangkok, , Thailand
Research Site, Songkhla, , Thailand
Research Site, Adana, , Turkey
Research Site, Istanbul, , Turkey
Research Site, Chernivtsі, , Ukraine
Research Site, Ivano-Frankivsk, , Ukraine
Research Site, Kharkiv, , Ukraine
Research Site, Kirovohrad, , Ukraine
Research Site, Kryvyi Rih, , Ukraine
Research Site, Kyiv, , Ukraine
Research Site, Kyiv, , Ukraine
Research Site, Kyiv, , Ukraine
Research Site, Sumy, , Ukraine
Research Site, Uzhhorod, , Ukraine
Research Site, Vinnytsia, , Ukraine
Research Site, London, , United Kingdom
Research Site, London, , United Kingdom
Research Site, Manchester, , United Kingdom
Research Site, Hanoi, , Vietnam
Contact Details
Name: Jared Weiss, MD
Affiliation: University of North Carolina, Chapel Hill
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
